- Home
- OLP vs AGMB Comparison
OLP vs AGMB Comparison
Compare OLP & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | AGMB |
|---|---|---|
| Founded | 1982 | 2017 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.9M | 652.5M |
| IPO Year | 1995 | 2024 |
Fundamental Metrics
Financial Performance| Metric | OLP | AGMB |
|---|---|---|
| Price | $23.10 | $12.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $26.75 | ★ $32.00 |
| AVG Volume (30 Days) | 50.1K | ★ 152.7K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | ★ 7.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $82,740,000.00 | N/A |
| Revenue This Year | $11.98 | N/A |
| Revenue Next Year | $3.71 | $17.86 |
| P/E Ratio | $23.20 | ★ N/A |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $19.62 | $8.75 |
| 52 Week High | $25.88 | $17.82 |
Technical Indicators
Market Signals| Indicator | OLP | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 45.81 |
| Support Level | $23.31 | $11.79 |
| Resistance Level | $23.63 | $14.94 |
| Average True Range (ATR) | 0.42 | 1.23 |
| MACD | -0.08 | -0.11 |
| Stochastic Oscillator | 16.42 | 14.95 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.